Arkadios Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.7M Buy
32,277
+3,121
+11% +$3.19M 0.59% 26
2026
Q1
$26.8M Buy
29,156
+1,363
+5% +$1.38M 0.44% 43
2025
Q4
$29.9M Buy
27,793
+6,386
+30% +$6.11M 0.58% 29
2025
Q3
$16.3M Buy
21,407
+3,760
+21% +$2.8M 0.39% 38
2025
Q2
$13.8M Buy
17,647
+5,327
+43% +$4.14M 0.41% 39
2025
Q1
$10.2M Buy
12,320
+5,572
+83% +$4.64M 0.38% 47
2024
Q4
$5.21M Buy
6,748
+207
+3% +$171K 0.28% 74
2024
Q3
$5.79M Buy
6,541
+1,089
+20% +$979K 0.33% 58
2024
Q2
$4.94M Buy
5,452
+1,541
+39% +$1.23M 0.33% 59
2024
Q1
$3.04M Buy
3,911
+107
+3% +$76.1K 0.24% 100
2023
Q4
$2.22M Sell
3,804
-116
-3% -$67.7K 0.19% 120
2023
Q3
$2.11M Buy
3,920
+1,380
+54% +$711K 0.2% 120
2023
Q2
$1.19M Sell
2,540
-339
-12% -$142K 0.14% 161
2023
Q1
$989K Buy
2,879
+614
+27% +$207K 0.12% 189
2022
Q4
$829K Sell
2,265
-123
-5% -$43.6K 0.11% 197
2022
Q3
$772K Sell
2,388
-25
-1% -$7.92K 0.12% 191
2022
Q2
$782K Sell
2,413
-217
-8% -$65.1K 0.12% 210
2022
Q1
$753K Sell
2,630
-617
-19% -$159K 0.1% 234
2021
Q4
$897K Buy
3,247
+186
+6% +$47.2K 0.12% 204
2021
Q3
$707K Sell
3,061
-470
-13% -$116K 0.1% 227
2021
Q2
$810K Sell
3,531
-1,123
-24% -$226K 0.1% 238
2021
Q1
$869K Buy
4,654
+3,055
+191% +$598K 0.14% 171
2020
Q4
$270K Buy
1,599
+1,085
+211% +$162K 0.06% 276
2020
Q3
$75.1K Buy
514
+8
+2% +$1.24K 0.04% 339
2020
Q2
$83K Sell
506
-23
-4% -$3.53K 0.05% 284
2020
Q1
$73.3K Sell
529
-157
-23% -$21.6K 0.05% 284
2019
Q4
$97.3K Buy
+686
New +$79.5K 0.06% 233

Other funds holding LLY

Arkadios Wealth Advisors's LLY Position: Q2 2026 in Review

Arkadios Wealth Advisors increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $3.19M and bringing the position to 32,277 shares worth $38.7M. The position accounts for 0.59% of the portfolio, ranked #26.

Arkadios Wealth Advisors first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Arkadios Wealth Advisors held 32,277 shares of Eli Lilly worth $38.7M as of Q2 2026.
  • Arkadios Wealth Advisors bought 3,121 Eli Lilly shares in Q2 2026, an estimated $3.19M.
  • Eli Lilly made up 0.59% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #26 holding.
  • Arkadios Wealth Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.